Osaic Holdings
CAI

Osaic Holdings’s Caris Life Sciences CAI Stock Holding History

Osaic Holdings’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
13,359
+7,431
+125% +$133K ﹤0.01% 4284
2026
Q1 		$106K Buy
5,928
+1,839
+45% +$40.2K ﹤0.01% 4637
2025
Q4 		$110K Buy
4,089
+3,639
+809% +$102K ﹤0.01% 4624
2025
Q3 		$16.9K Sell
450
-550
-55% -$17.5K ﹤0.01% 6041
2025
Q2 		$26.7K Buy
+1,000
New +$26.9K ﹤0.01% 5493

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Osaic Holdings's CAI Position: Q2 2026 in Review

Osaic Holdings increased its Caris Life Sciences (CAI) stake by 125% in Q2 2026, buying an estimated $133K and bringing the position to 13,359 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #4284.

Osaic Holdings first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Osaic Holdings held 13,359 shares of Caris Life Sciences worth $238K as of Q2 2026.
  • Osaic Holdings bought 7,431 Caris Life Sciences shares in Q2 2026, an estimated $133K.
  • Caris Life Sciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4284 holding.
  • Osaic Holdings first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.